Founding Group
We would like to thank our Founding Group who have dedicated their expertise to creating the scientific programme for this meeting.
Alex Miras
Alex Miras is Professor of Endocrinology at Ulster University. His clinical and research work focus solely on Obesity and type 2 diabetes. He has contributed to clinical management policy and research in the field of Obesity over the last 14 years.
The specialist interests of his research group are the mechanisms of action of interventions for obesity, focusing on pharmacotherapy, medical devices, and obesity surgery.
Alex is a member of the NICE obesity management guidelines committee, trustee of the Association for the Study of Obesity and chair of the research subcommittee of the NBSR. He is associate editor for the journals Obesity and SOARD.
The specialist interests of his research group are the mechanisms of action of interventions for obesity, focusing on pharmacotherapy, medical devices, and obesity surgery.
Alex is a member of the NICE obesity management guidelines committee, trustee of the Association for the Study of Obesity and chair of the research subcommittee of the NBSR. He is associate editor for the journals Obesity and SOARD.
John Wilding
Professor John Wilding leads clinical research into Obesity, Diabetes and Endocrinology at the University of Liverpool, where he has worked since 1996, after training in Southampton and London. His clinical interests focus on caring for people with diabetes and obesity and he leads specialist services for obesity at Aintree University Hospital – designated a Centre for Obesity Management by the European Association for the Study of Obesity.
John’s research team focusses on developing and evaluating treatments for obesity and type 2 diabetes. He has published over 350 papers, chapters and review articles, including clinical trials in diabetes and obesity, as well as studies of adipocyte biology and metabolism.
He has advised NICE and NHS England on various aspects of obesity care. He is past President of the World Obesity Federation.
John’s research team focusses on developing and evaluating treatments for obesity and type 2 diabetes. He has published over 350 papers, chapters and review articles, including clinical trials in diabetes and obesity, as well as studies of adipocyte biology and metabolism.
He has advised NICE and NHS England on various aspects of obesity care. He is past President of the World Obesity Federation.
